These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37044373)
21. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice. Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1. Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440 [TBL] [Abstract][Full Text] [Related]
23. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells. Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220 [No Abstract] [Full Text] [Related]
24. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114 [TBL] [Abstract][Full Text] [Related]
28. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149 [TBL] [Abstract][Full Text] [Related]
29. Liver adrenoceptor alpha-1b plays a key role in energy and glucose homeostasis in female mice. Silva A; Mouchiroud M; Lavoie O; Beji S; Elmquist JK; Caron A Am J Physiol Endocrinol Metab; 2024 Nov; 327(5):E626-E635. PubMed ID: 39259165 [TBL] [Abstract][Full Text] [Related]
30. Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or systemic lipolysis in rat. Liu Z; Zhang L; Qian C; Zhou Y; Yu Q; Yuan J; Lv Y; Zhang L; Chang X; Li Y; Liu Y Metabolism; 2022 Nov; 136():155310. PubMed ID: 36063868 [TBL] [Abstract][Full Text] [Related]
31. Prostaglandin F Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555 [TBL] [Abstract][Full Text] [Related]
32. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway. Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267 [TBL] [Abstract][Full Text] [Related]
33. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Vecchi C; Montosi G; Garuti C; Corradini E; Sabelli M; Canali S; Pietrangelo A Gastroenterology; 2014 Apr; 146(4):1060-9. PubMed ID: 24361124 [TBL] [Abstract][Full Text] [Related]
34. Hepatic gluconeogenesis and the activity of PDH in individual tissues of GTG-obese mice following adrenalectomy. Blair SC; Greenaway TM; Bryson JM; Phuyal JL; Wensley VR; Caterson ID; Cooney GJ Obes Res; 1996 Jul; 4(4):367-75. PubMed ID: 8822761 [TBL] [Abstract][Full Text] [Related]
35. Glutamine administration promotes hepatic glucose homeostasis through regulating the PI3K/Akt pathway in high-fat diet-induced obese mice with limb ischemia. Pitaloka DMI; Ko CH; Lin MT; Yeh SL; Yeh CL Nutr Res; 2019 Aug; 68():45-53. PubMed ID: 31419579 [TBL] [Abstract][Full Text] [Related]
36. Genetic ablation of Fas-activated serine/threonine kinase ameliorates obesity-related hepatic glucose and lipid metabolic disorders via sirtuin-1 signaling. Zhang F; Pei J; Chen X Biochem Biophys Res Commun; 2020 Sep; 529(4):1066-1072. PubMed ID: 32819566 [TBL] [Abstract][Full Text] [Related]
37. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis. Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404 [TBL] [Abstract][Full Text] [Related]
38. The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity. Rauckhorst AJ; Gray LR; Sheldon RD; Fu X; Pewa AD; Feddersen CR; Dupuy AJ; Gibson-Corley KN; Cox JE; Burgess SC; Taylor EB Mol Metab; 2017 Nov; 6(11):1468-1479. PubMed ID: 29107293 [TBL] [Abstract][Full Text] [Related]
39. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis. Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215 [TBL] [Abstract][Full Text] [Related]
40. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance. Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]